Health
UK Launches 3rd Booster Dose Trial of 7 COVID-19 Vaccines Including Oxford-AstraZeneca, Pfizer-BioNTech And – LatestLY
In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different COVID-19 vaccines on patients’ immune…
London, May 21: In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different COVID-19 vaccines on patients’ immune responses, the media reported.
The trial will assess COVID-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac. COVID-19 Cases Will Rise Despite Vaccination: UK Scientists
The trial, named Cov-Boost, aims to begin in June and recruit 3,000 people of all ages who had their…
-
General13 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News21 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News13 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News20 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime